Related Experiment Video
Updated: Sep 15, 2025

Using Caenorhabditis elegans for Studying Trans- and Multi-Generational Effects of Toxicants
Published on: July 29, 2019
Impact of early life antibiotic exposure on the preschool developmental status: a nationwide population-based study
Ye Kyung Kim1,2, Peong Gang Park3
1Department of Pediatrics, Konkuk University Medical Center, Seoul, Korea (the Republic of).
Insights
Early antibiotic exposure in infants under 90 days old is linked to a modest increase in developmental delays, particularly affecting motor skills, cognition, and communication. Longer exposure duration correlates with higher risk, necessitating careful prescription practices.
Area of Science:
- Pediatric Neurodevelopment
- Pharmacology and Toxicology
Background:
- Growing concerns surround early antibiotic exposure's impact on neurodevelopmental outcomes.
- Large-scale studies on this topic in early childhood are limited.
Purpose of the Study:
- To investigate the association between early-life antibiotic exposure and developmental delays in preschool-aged children.
- To assess the risk of global and domain-specific developmental delays following antibiotic use within the first 90 days of life.
Main Methods:
- A nationwide, population-based retrospective cohort study.
- Utilized data from the Korean National Health Insurance System and NHSPIC (2015-2022).
- Included 1,848,841 children assessed at 4-6 months and 54-60 months of age.
Main Results:
- 23% of infants received antibiotics within the first 3 months of life.
- Early antibiotic exposure showed a slight increase in developmental delay risk (OR 1.03).
- Delays were noted in gross motor, fine motor, cognition, and communication, with a dose-response relationship observed.
Conclusions:
- Antibiotic exposure in the first 90 days of life may be associated with a modest increase in global developmental delays.
- Motor skills, cognitive functions, and communication abilities appear particularly affected.
- Prudent antibiotic prescribing for infants under 90 days is recommended.
Objective:
Growing concerns exist about the potential adverse effects of early antibiotic exposure on neurodevelopmental outcomes. However, large-scale studies exploring these implications in early childhood are rare.
Design:
A nationwide, population-based retrospective cohort study using data from the Korean National Health Insurance System and the National Health Screening Program for Infants and Children (NHSPIC) between 2015 and 2022.
Patients:
A total of 1 848 841 children who participated in the NHSPIC at both 4-6 months and 54-60 months of age were included.
Interventions:
Antibiotic exposure under 90 days old.
Main Outcome Measures:
Developmental delays in preschool-aged children assessed by the Korean Developmental Screening Test at 54-60 month of age.
Results:
Among the 1 848 841 children assessed, 23% experienced antibiotic exposure within the first 3 months of life. Early use of antibiotics was linked to a slightly elevated risk of developmental delays at a median age of 4.94 years (OR 1.03, 95% CI 1.00 to 1.17), particularly affecting gross motor (OR 1.08, 95% CI 1.04 to 1.13), fine motor (OR 1.09, 95% CI 1.05 to 1.13), cognition (OR 1.08, 95% CI 1.04 to 1.13) and communication (OR 1.08, 95% CI 1.04 to 1.12). A dose-response relationship was also observed, with longer durations of antibiotic exposure associated with an increased risk of developmental delays.
Conclusions:
Exposure to antibiotics in infants under 90 days old may be associated with a modest increase in the risk of global developmental delays, especially in motor skills, cognitive functions and communication abilities. Careful consideration is necessary when prescribing antibiotics to this age group.
Related Concept Videos
Environmental Influences on Intelligence
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Development of Antibiotic Resistance
Factors Affecting Drug Response: Overview
Antibiotic Selection

